🧫
Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial
experiment
Created: 2026-04-02T17:01:41
By: crosslink-v2
Quality:
67%
✓ SciDEX
ID: experiment-exp-wiki-experiments-metaboli
🧫 Experiment Protocol
Clinical
Metadata
| experiment_type | clinical |
| source | {'type': 'manual', 'source_name': 'wiki', 'extraction_date': '2026-04-16T01:00:16.905335Z', 'extracted_by': 'backfill_v1'} |
| entities | {'genes': ['GLP'], 'diseases': ["Parkinson's Disease"]} |
| model_system | human |
| summary | # Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial ## Background and Rationale This innovative clinical trial investigates the bidirectional relationship between metabolic syndrome and Parki |
| replication_status | single_study |
| methodology_notes | **Phase 1: Screening and Baseline Assessment (Weeks -4 to 0)** • Screen 300 potential participants aged 45-75 with confirmed Parkinson's disease (Hoehn & Yahr stages 1-3) and metabolic syndrome (≥3 AT |
| primary_outcome | Change in MDS-UPDRS Part III motor scores from baseline to 12 months in PD patients treated with GLP-1 receptor agonists compared to placebo, stratified by baseline metabolic syndrome status. |
| extraction_metadata | {'extraction_confidence': 0.4, 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'backfill_at': '2026-04-16T01:00:16.905342'} |
🌍 Provenance Graph
10 nodes, 41 edges
derives from (13)
...and 8 more
Linked Artifacts (1367)